MedAI Verdict
All comparisons

Cleerly vs Gleamer

Cleerly's openFDA records run under three product names. Cleerly Labs has decisions in November 2019 (K190868), October 2020, March 2025 and July 2026, Cleerly ISCHEMIA one in September 2023 and Cleerly Plaque one in July 2026. The vendor says its serial CCTA comparison tracks plaque change.

RadNet announced in March 2026 that it had acquired Gleamer for up to EUR 230M, to be integrated into DeepHealth. openFDA names BoneView, BoneMetrics and ChestView under the Gleamer name, the latest decision in September 2026, plus Pixyl.Neuro under Pixyl SA. The vendor also lists LungCT, BoneCT and BreastView, and the openFDA records under the Gleamer name do not show their US status.

Cleerly reads coronary CT angiograms and Gleamer reads emergency radiographs and chest films. A US imaging group adding AI would match Cleerly to cardiac CT and Gleamer to X-ray, each in its own reading room.

Radiology · Reviewed November 2, 2026

Cleerly logo

Cleerly

by Cleerly

AI-driven CCTA plaque quantification + CAD staging.

Gleamer logo

Gleamer

by Gleamer SAS

Radiology AI for fracture and chest X-ray findings, plus CT, MRI and mammography; part of RadNet DeepHealth since March 2026.

When to pick each one

Cleerly

  • Cleerly Labs, ISCHEMIA and Plaque all named in openFDA
  • Vendor says serial CCTA comparison tracks plaque change
Read the full Cleerly review

Gleamer

  • BoneView, BoneMetrics and ChestView named in openFDA
  • Part of RadNet's DeepHealth since March 2026
  • Vendor lists CT, MRI and mammography tools beyond X-ray
Read the full Gleamer review

Score

Each row shows points earned of points available under the published rubric.

Cleerly

52of 100

Solid choice

Gleamer

56of 100

Solid choice
Score by dimension for Cleerly and Gleamer
DimensionCleerlyGleamerDifference
FDA clearance18 / 1818 / 180
HIPAA / SOC2 / BAA0 / 100 / 100
EHR integrations (count)0 / 4.20 / 4.20
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.40 / 2.40
Peer-reviewed papers12.7 / 18.218.2 / 18.2-5.5
RCT / meta-analysis / systematic review3.9 / 7.80 / 7.8+3.9
Funding & adoption signal6 / 128.4 / 12-2.4
Pricing transparency2.5 / 52.5 / 50
Years in market0 / 60 / 60

Scroll horizontally to see every column.

How scores are computed

Pricing

Cleerly

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. The homepage offers a demo request.

Gleamer

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. Demo request only.

Compliance and integrations

Documented from each vendor’s own pages.

SpecCleerlyGleamer
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot specifiedNot specified
Foundedn/an/a
HQUSFR

Scroll horizontally to see both columns.

Common questions

Open the full radiology comparison

Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.